European Primary Care Cardiovascular Society

EPCCS CV Summit 2019

The EPCCS Summit aimed to provide updates, consensus and guidance on management of CV disease in European primary care.

Heart failure and comorbidities: kidney disease and cancer

5' education - Mar. 22, 2019 - Lisbon, Portugal - Peter van der Meer & Monika Hollander
Monika Hollander asks Peter van der Meer how comorbidities like renal dysfunction and cancer treatment affect management of patients with HF: what is known about treatment in patients with these comorbidities?

EPCCS 2019 Monika Hollander asks Peter van der Meer how comorbidities like renal dysfunction and cancer treatment affects management of patients with HF: what is known about treatment in patients with these comorbidities?

New diagnostic algorithm and therapeutic options in HF management

5' education - Mar. 22, 2019 - Lisbon, Portugal - Peter van der Meer & Monika Hollander
Professor Peter van der Meer & Monika Hollander consider new recommendations in the latest ESC Guidelines on diagnosis and treatment of patients with HF, and the role GPs may play in this process.

EPCCS 2019 Professor Peter van der Meer & Monika Hollander consider new recommendations in the latest ESC Guidelines on diagnosis and treatment of patients with HF, and the role GPs may play in this process.

Update on managing CV risk in diabetes: what's the evidence?

5' education - Mar. 22, 2019 - Lisbon, Portugal - Kamlesh Khunti & Richard Hobbs
Profs Khunti and Hobbs discuss why CV risk needs attention in patients with diabetes, and how this risk can be mitigated. They also consider barriers that prevent optimal implementation of the evidence on effective management strategies.

EPCCS 2019 Profs Khunti and Hobbs discuss why CV risk needs attention in patients with diabetes, and how this can be mitigated. They also consider barriers that prevent optimal implementation of the evidence on effective management strategies.

Stroke prevention in atrial fibrillation

5' education - Mar. 21, 2019 - Lisbon, Portugal - Michaela Machácová & Richard Hobbs
Dr. Machácová and prof. Hobbs discuss steps of management of patients with atrial fibrillation, from identification to treatment to lower the associated stroke risk, including best practice when optimal options are unavailable.

EPCCS 2019 Dr. Machácová and prof. Hobbs discuss steps of management of patients with atrial fibrillation, from identification to treatment to lower the associated stroke risk, including best practice when optimal options are unavailable.

Education, exchange, guidance and interaction during EPCCS Summit 2019

EPCCS Annual CV Summit

EPCCS 2019 Read impressions of the updates on stroke prevention in AF, hypertension, HF and CV risk in diabetes, with emphasis on challenges faced in patients with multimorbidities.

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs
Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Multimorbidity, CV disease and polypharmacy

10' education - Mar. 21, 2019 - Lisbon, Portugal - Dr. David Silvério Rodrigues
Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

EPCCS 2019 Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

Complexities of managing heart failure

EPCCS Annual CV Summit

EPCCS Annual CV Summit

EPCCS 2019 Read an impression of the presentation of prof. Van der Meer, on the latest recommendations on management of HF, including important aspects to consider in patients with comorbidities.

Slides | What's the evidence that diabetes is linked to CVD risk?

Slides (presentation) - Mar. 22, 2019 - Prof. Richard Hobbs
**EPCCS 2019** Slides prepared and presented by prof. **Richard Hobbs** (Oxford, United Kingdom), here offered as an educational service.

EPCCS 2019 Slides prepared and presented by prof. Richard Hobbs (Oxford, United Kingdom), here offered as an educational service.

Slides | Diabetes and cardiovascular risk

Slides (presentation) - Mar. 22, 2019 - Lisbon, Portugal - Prof. Kamlesh Khunti
**EPCCS 2019** Slides prepared and presented by prof. **Kamlesh Khunti** (Leicester, UK) here offered as an educational service.

EPCCS 2019 Slides prepared and presented by prof. Kamlesh Khunti (Leicester, UK) here offered as an educational service.

Slides | Complexities of managing heart failure

Slides (presentation) - Mar. 22, 2019 - Lisbon, Portugal - Prof. Peter van der Meer
**EPCCS 2019** Slides prepared and presented by prof. **Peter van der Meer** (Groningen, The Netherlands), here offered as an educational service.

EPCCS 2019 Slides prepared and presented by prof. Peter van der Meer (Groningen, The Netherlands), here offered as an educational service.

Slides | Recent updates to the International Hypertension guidelines - where do they vary and what should we agree in primary care?

Slides (presentation) - Mar. 21, 2019 - Lisbon, Portugal - Prof. Richard McManus
**EPCCS 2019** Slides prepared and presented by prof. **Richard McManus** (Oxford, UK) here offered as an educational service.

EPCCS 2019 Slides prepared and presented by prof. Richard McManus - Oxford, UK, here offered as an educational service.

EPCCS CV Summit 2019